While their immunomodulatory effects, including macrophage repolarization, contribute to their broader anti-tumor mechanism, future studies are needed to elucidate the specific pathways involved and to optimize strategies for combining OVs with macrophage-repolarizing therapies like CSF1R inhibitors to improve clinical outcomes (206). This evidence concerns the gene CSF1R and neoplasm.